End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.16 CNY | +5.04% | +5.39% | -33.89% |
Apr. 26 | Pharmaron Beijing Posts 34% Profit Drop in Q1 as Revenue Slips 2% | MT |
Apr. 26 | Nomura Adjusts Pharmaron Beijing Co's Price Target to HK$15.41 From HK$17.99, Keeps at Buy | MT |
Evolution of the average Target Price on Pharmaron Beijing Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pharmaron Beijing Co., Ltd.
Nomura | |
UBS |
EPS Revisions
- Stock Market
- Equities
- 300759 Stock
- Consensus Pharmaron Beijing Co., Ltd.